In vitro assessment of the sensitivity to APR‐246 + azacitidine combination predicts response to this combination in myelodysplastic/acute myeloid leukaemia patients. (17th June 2021) - Maslah, Nabih; Diawara, Yantcha; Sebert, Marie; Giraudier, Stephane; Fenaux, Pierre; Cassinat, Bruno